Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continuing their series celebrating ‘amazing people at Oxford who you should know about’, Central University's Science Blog talks to Dayne Beccano-Kelly, an electrophysiologist and Career Development Fellow in our department and part of the Oxford Parkinson’s Disease Centre.

With more than ten years’ experience in the field, Dayne discusses his research using human neurons to improve treatments and the quality of life for people with neurodegenerative conditions such as Parkinson’s disease. He also shares how he is aiming to tackle the lack of BAME leadership opportunities in STEM, by mentoring and inspiring black and minority ethnic scientists of tomorrow.

How would you describe your journey to Oxford?

I am from Cardiff originally, and took my undergraduate degree at Leeds University in bio-chemistry, as a route into medicine. But, after my first year, I changed my mind with a stint in research, as part of my year in industry.

Time and experience showed me that what I really wanted to do was science research, helping people, but being the one to garner the knowledge that would help. It is fun to be continually asking the questions, and driving the conversation on known scientific knowledge.

Was Oxford what you expected it to be?

Oxford is a melting pot of scientific ideas that are often brewing a stone’s throw away, which makes it easier to interact with other scientists and develop collaborations.

I have been here four years now and don’t feel marginalised at Oxford. I expected there to be a low number of BAME academics at Oxford, because there have been at every other institution.

Having lived in Vancouver directly before this, which I loved in a different way, I can feel the contrast. It’s great to be surrounded by so much history. Vancouver is younger than Arsenal FC, my football team.

 

Read the full interview on the University of Oxford's Science Blog.

Similar stories

Oxford Parkinson’s Disease Centre collaborators announced as Group Leaders for new Parkinson’s Research Centre

Congratulations to Oxford Parkinson’s Disease Centre (OPDC) investigators, Professor Peter Magill, Professor of Neurobiology, Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, and Professor Laura Parkkinen, Professor of Translational Neuropathology, Nuffield Department of Clinical Neurosciences on their appointment to Group Leader roles in the new Parkinson’s Research Centre (PRC) - a £10m partnership between Parkinson’s UK and the UK Dementia Research Institute (UK DRI) dedicated to better understand the causes of Parkinson’s and to accelerate new and improved treatments for the condition.

Oxford researchers join global network unravelling the complexity of Parkinson’s disease

Professor Andrew Sharott (Team leader) and Professor Laura Parkkinen (Co-Investigator) from Nuffield Department of Clinical Neurosciences (NDCN) have been selected for multi-year grants to join the Collaborative Research Network (CRN) an international, multidisciplinary, multi-institutional network working to address high-priority research questions about Parkinson's disease. Read full story: https://www.medsci.ox.ac.uk/news/oxford-researchers-join-global-network-unravelling-the-complexity-of-parkinsons-disease